236
60. Bocio A, Llobet J, Domingo J, Corbella J, Teixido A, Casas C. Polybrominated diphenyl ethers (PBDEs) in foodstuffs: human exposure through the diet. J Agric Food Chem.
2003;51(10):3191–5.
61. McDonald TA. A perspective on the potential health risks of PBDEs. Chemosphere.
2002;46(5):745–55.
62. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ
Epidemiol. 2008;18(1):2.
63. Jones OA, Maguire ML, Griffin JL. Environmental pollution and diabetes: a neglected association. Lancet. 2008;371(9609):287–8.
64. Lee D-H, Lee I-K, Steffes M, Jacobs DR. Extended analyses of the association between
serum concentrations of persistent organic pollutants and diabetes. Diabetes Care.
2007;30(6):1596–8.
65. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin
resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes. 2003;111(03):121–4.
66. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition
of glucose uptake. J Clin Invest. 1994;93(6):2438–46.
67. Lim J-S, Lee D-H, Jacobs DR. Association of brominated flame retardants with diabetes and
metabolic syndrome in the US population, 2003–2004. Diabetes Care. 2008;31(9):1802–7.
68. Lee D-H, Lee I-K, Song K, Steffes M, Toscano W, Baker BA, et al. A strong doseresponse relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care.
2006;29(7):1638–44.
69. Griffin JL, Scott J, Nicholson JK. The influence of pharmacogenetics on fatty liver disease
in the Wistar and Kyoto rats: a combined transcriptomic and metabonomic study. J Proteome
Res. 2007;6(1):54–61.
70. Azmi J, Griffin J, Shore R, Holmes E, Nicholson J. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of
1-naphthylisothiocyanate from its products. Xenobiotica. 2005;35(8):839–52.
71. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol
A at environmentally relevant doses inhibits adiponectin release from human adipose tissue
explants and adipocytes. Environ Health Perspect. 2008;116(12):1642–7. Epub 2008/12/17.
eng.
72. Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect. 2002;110(9):853–8.
73. Safe S, Hutzinger O. Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): biochemistry, toxicology, and mechanism of action. CRC Crit Rev Toxicol.
1984;13(4):319–95.
74. Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health
Perspect. 2004;112(1):9–17.
75. De Wit CA. An overview of brominated flame retardants in the environment. Chemosphere.
2002;46(5):583–624.
76. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L,
et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet
Oncol. 2013;14(4):287.
77. Darnerud PO. Toxic effects of brominated flame retardants in man and in wildlife. Environ
Int. 2003;29(6):841–53.
78. Jacobson JL, Fein GG, Jacobson SW, Schwartz PM, Dowler JK. The transfer of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs) across the human placenta
and into maternal milk. Am J Public Health. 1984;74(4):378–9.
79. National Toxicology Program. NTP toxicology and carcinogenesis studies of polybrominated
biphenyls (CAS No. 67774-32-7)(Firemaster FF-1 (R)) in F344/N rats and B6C3F1 mice
(feed studies). National Toxicology Program technical report series; 1993, vol. 398, p. 1.
T. Hussain et al.
60. Bocio A, Llobet J, Domingo J, Corbella J, Teixido A, Casas C. Polybrominated diphenyl ethers (PBDEs) in foodstuffs: human exposure through the diet. J Agric Food Chem.
2003;51(10):3191–5.
61. McDonald TA. A perspective on the potential health risks of PBDEs. Chemosphere.
2002;46(5):745–55.
62. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J Expo Sci Environ
Epidemiol. 2008;18(1):2.
63. Jones OA, Maguire ML, Griffin JL. Environmental pollution and diabetes: a neglected association. Lancet. 2008;371(9609):287–8.
64. Lee D-H, Lee I-K, Steffes M, Jacobs DR. Extended analyses of the association between
serum concentrations of persistent organic pollutants and diabetes. Diabetes Care.
2007;30(6):1596–8.
65. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin
resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes. 2003;111(03):121–4.
66. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition
of glucose uptake. J Clin Invest. 1994;93(6):2438–46.
67. Lim J-S, Lee D-H, Jacobs DR. Association of brominated flame retardants with diabetes and
metabolic syndrome in the US population, 2003–2004. Diabetes Care. 2008;31(9):1802–7.
68. Lee D-H, Lee I-K, Song K, Steffes M, Toscano W, Baker BA, et al. A strong doseresponse relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care.
2006;29(7):1638–44.
69. Griffin JL, Scott J, Nicholson JK. The influence of pharmacogenetics on fatty liver disease
in the Wistar and Kyoto rats: a combined transcriptomic and metabonomic study. J Proteome
Res. 2007;6(1):54–61.
70. Azmi J, Griffin J, Shore R, Holmes E, Nicholson J. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of
1-naphthylisothiocyanate from its products. Xenobiotica. 2005;35(8):839–52.
71. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol
A at environmentally relevant doses inhibits adiponectin release from human adipose tissue
explants and adipocytes. Environ Health Perspect. 2008;116(12):1642–7. Epub 2008/12/17.
eng.
72. Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect. 2002;110(9):853–8.
73. Safe S, Hutzinger O. Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): biochemistry, toxicology, and mechanism of action. CRC Crit Rev Toxicol.
1984;13(4):319–95.
74. Birnbaum LS, Staskal DF. Brominated flame retardants: cause for concern? Environ Health
Perspect. 2004;112(1):9–17.
75. De Wit CA. An overview of brominated flame retardants in the environment. Chemosphere.
2002;46(5):583–624.
76. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L,
et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet
Oncol. 2013;14(4):287.
77. Darnerud PO. Toxic effects of brominated flame retardants in man and in wildlife. Environ
Int. 2003;29(6):841–53.
78. Jacobson JL, Fein GG, Jacobson SW, Schwartz PM, Dowler JK. The transfer of polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs) across the human placenta
and into maternal milk. Am J Public Health. 1984;74(4):378–9.
79. National Toxicology Program. NTP toxicology and carcinogenesis studies of polybrominated
biphenyls (CAS No. 67774-32-7)(Firemaster FF-1 (R)) in F344/N rats and B6C3F1 mice
(feed studies). National Toxicology Program technical report series; 1993, vol. 398, p. 1.
T. Hussain et al.